FDA Warns Of ‘Severe Adverse Reactions’ After Vaccine Dose 2
Pfizer and partner BioNTech’s COVID-19 vaccine meets expectations on agency guidance and is enough to spur an agency review, according to staff of the U.S. Food and Drug Administration. The finding is one of several significant new results featured in the briefing...